Clindamycin/primaquine for treatment ofPneumocystis carinii pneumonia in AIDS

Publisher Website
Google Scholar
Abstract
In an open clinical trial, 109 episodes ofPneumocystis carinii pneumonia (70 proven and 39 highly probable) were treated with clindamycin/primaquine. These episodes were in 35 patients who failed on standard therapy and 15 who did not tolerate standard therapy; 59 patients received this regimen as their initial treatment. The clinical outcome was excellent with only 8 cases of failures encountered (6 patients also failed on standard therapy). The onset of clinical response was obvious in less than 72 hours in 81% of patients; the relapse rate was very low. The regimen was well tolerated and compares advantageously with conventional therapy forPneumocystis carinii pneumonia.